Beth Israel Medical Center BIMC — New York, New York

Beth Israel Medical Center BIMC is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Medical Center BIMC has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, HER2+ Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Medical Center BIMC?

Beth Israel Medical Center BIMC has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Medical Center BIMC conducted?

Beth Israel Medical Center BIMC has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, HER2+ Breast Cancer.

Is Beth Israel Medical Center BIMC accredited by Crixeo Health?

Beth Israel Medical Center BIMC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Medical Center BIMC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.